What is Silexion Therapeutics Corp Ordinary Shares's Market Cap?

Silexion Therapeutics Corp Ordinary Shares's Market Cap is $1.9M, based on as-reported figures from SEC (XBRL) filings.

What is Silexion Therapeutics Corp Ordinary Shares's Enterprise Value?

Silexion Therapeutics Corp Ordinary Shares's Enterprise Value is -$285.7K, based on as-reported figures from SEC (XBRL) filings.

What is Silexion Therapeutics Corp Ordinary Shares's EV / EBITDA?

Silexion Therapeutics Corp Ordinary Shares's EV / EBITDA is 0.0×, based on as-reported figures from SEC (XBRL) filings.

What is Silexion Therapeutics Corp Ordinary Shares's Net Income (TTM)?

Silexion Therapeutics Corp Ordinary Shares's Net Income (TTM) is -$14.0M, based on as-reported figures from SEC (XBRL) filings.

What is Silexion Therapeutics Corp Ordinary Shares's Diluted EPS (TTM)?

Silexion Therapeutics Corp Ordinary Shares's Diluted EPS (TTM) is -2.51, based on as-reported figures from SEC (XBRL) filings.

What is Silexion Therapeutics Corp Ordinary Shares's Net Debt?

Silexion Therapeutics Corp Ordinary Shares's Net Debt is -$2.2M, based on as-reported figures from SEC (XBRL) filings.

Silexion Therapeutics Corp Ordinary Shares (SLXN) Financial Statements

Silexion Therapeutics Corp Ordinary Shares

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG01PBJB8F3

XNAS · usd

0.35▲ 0.00 (1.33%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close0.34

Day's Range0.34 – 0.36

52-Week Range0.23 – 7.77

Volume66.7K

Avg Volume422.1K

Share Statistics

Shares Outstanding

Employees13

ExchangeXNAS

Listed2024-08-16

Share count as of August 13, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Silexion Therapeutics Corp Ordinary Shares (SLXN)

What is Silexion Therapeutics Corp Ordinary Shares's Market Cap?: Silexion Therapeutics Corp Ordinary Shares's Market Cap is $1.9M, based on as-reported figures from SEC (XBRL) filings.
What is Silexion Therapeutics Corp Ordinary Shares's Enterprise Value?: Silexion Therapeutics Corp Ordinary Shares's Enterprise Value is -$285.7K, based on as-reported figures from SEC (XBRL) filings.
What is Silexion Therapeutics Corp Ordinary Shares's EV / EBITDA?: Silexion Therapeutics Corp Ordinary Shares's EV / EBITDA is 0.0×, based on as-reported figures from SEC (XBRL) filings.
What is Silexion Therapeutics Corp Ordinary Shares's Net Income (TTM)?: Silexion Therapeutics Corp Ordinary Shares's Net Income (TTM) is -$14.0M, based on as-reported figures from SEC (XBRL) filings.
What is Silexion Therapeutics Corp Ordinary Shares's EBITDA?: Silexion Therapeutics Corp Ordinary Shares's EBITDA is -$14.1M, based on as-reported figures from SEC (XBRL) filings.
What is Silexion Therapeutics Corp Ordinary Shares's Diluted EPS (TTM)?: Silexion Therapeutics Corp Ordinary Shares's Diluted EPS (TTM) is -2.51, based on as-reported figures from SEC (XBRL) filings.
What is Silexion Therapeutics Corp Ordinary Shares's Net Debt?: Silexion Therapeutics Corp Ordinary Shares's Net Debt is -$2.2M, based on as-reported figures from SEC (XBRL) filings.